CorMedix
CRMD
198 hedge funds and large institutions have $488M invested in CorMedix in 2025 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 79 increasing their positions, 56 reducing their positions, and 29 closing their positions.
57% more call options, than puts
Call options by funds: $28.3M | Put options by funds: $18M
41% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 56
34% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 29
4% more funds holding
Funds holding: 190 → 198 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $502M → $488M (-$13.8M)
2.01% less ownership
Funds ownership: 55.24% → 53.24% (-2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$52.8M |
| 2 |
Goldman Sachs
New York
|
+$6.61M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.76M |
| 4 |
Lazard Asset Management
New York
|
+$3M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$2.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$24.5M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$16.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15.4M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$7.41M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$7.05M |
CRMD Hedge Fund Activity: Q4 2025 in Review
198 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2025, worth a combined $488M — down 2.7% from $502M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new CRMD positions and 29 closed out — a net gain of 10 holders — while 79 added to existing stakes and 56 trimmed.
The largest buyer was Deep Track Capital, adding an estimated $52.8M. The largest seller was Deerfield Management, cutting an estimated $24.5M.
- 198 institutional investors held CorMedix (CRMD) as of Q4 2025, up from 190 in Q3 2025.
- Funds reported $488M of CorMedix stock for Q4 2025, down 2.7% quarter-over-quarter.
- 39 funds opened new CorMedix positions in Q4 2025 and 29 closed out, a net change of +10 holders.
- The largest CorMedix buyer in Q4 2025 was Deep Track Capital, an estimated $52.8M added.
- The largest CorMedix seller in Q4 2025 was Deerfield Management, an estimated $24.5M sold.
Based on aggregated 13F filings for Q4 2025.